-
Aisenberg, A. C., Wilkes, B. M., Jacobson, J. O. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 71: 969-972, 1988. [PubMed: 2965608]
-
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., Korsmeyer, S. J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around J(H) on chromosome 14 and near a transcriptional unit on 18. Cell 41: 899-906, 1985. [PubMed: 3924412] [Full Text: https://doi.org/10.1016/s0092-8674(85)80070-2]
-
Bakhshi, A., Wright, J. J., Graninger, W., Seto, M., Owens, J., Cossman, J., Jensen, J. P., Goldman, P., Korsmeyer, S. J. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc. Nat. Acad. Sci. 84: 2396-2400, 1987. [PubMed: 3104914] [Full Text: https://doi.org/10.1073/pnas.84.8.2396]
-
Cang, S., Iragavarapu, C., Savooji, J., Song, Y., Liu, D. ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. J. Hemat. Oncol. 8: 129, 2015. Note: Electronic Article. [PubMed: 26589495] [Full Text: https://doi.org/10.1186/s13045-015-0224-3]
-
Chen, J., Flannery, J. G., LaVail, M. M., Steinberg, R. H., Xu, J., Simon, M. I. Bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc. Nat. Acad. Sci. 93: 7042-7047, 1996. [PubMed: 8692941] [Full Text: https://doi.org/10.1073/pnas.93.14.7042]
-
Ciechomska, I. A., Goemans, G. C., Skepper, J. N., Tokovsky, A. M. Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function. Oncogene 28: 2128-2141, 2009. [PubMed: 19347031] [Full Text: https://doi.org/10.1038/onc.2009.60]
-
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C., Kipps, T. J., Negrini, M., Croce, C. M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Nat. Acad. Sci. 102: 13944-13949, 2005. Note: Erratum: Proc. Nat. Acad. Sci. 103: 2464-2465, 2006. [PubMed: 16166262] [Full Text: https://doi.org/10.1073/pnas.0506654102]
-
Cleary, M. L., Sklar, J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Nat. Acad. Sci. 82: 7439-7443, 1985. [PubMed: 2865728] [Full Text: https://doi.org/10.1073/pnas.82.21.7439]
-
Cleary, M. L., Smith, S. D., Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47: 19-28, 1986. [PubMed: 2875799] [Full Text: https://doi.org/10.1016/0092-8674(86)90362-4]
-
Croce, C. M. Personal Communication. Philadelphia, Pa. 1989.
-
Das, R., Reddy, E. P., Chatterjee, D., Andrews, D. W. Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma. Oncogene 12: 947-951, 1996. Note: Erratum: Oncogene 16: 429 only, 1998. [PubMed: 8649811]
-
Del Gaizo Moore, V., Brown, J. R., Certo, M., Love, T. M., Novina, C. D., Letai, A. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J. Clin. Invest. 117: 112-121, 2007. [PubMed: 17200714] [Full Text: https://doi.org/10.1172/JCI28281]
-
Deng, G., Podack, E. R. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Nat. Acad. Sci. 90: 2189-2193, 1993. [PubMed: 8460122] [Full Text: https://doi.org/10.1073/pnas.90.6.2189]
-
DiCroce, P. A., Krontiris, T. G. The BCL2 major breakpoint region is a sequence- and cell-cycle-specific binding site of the Ku antigen. Proc. Nat. Acad. Sci. 92: 10137-10141, 1995. [PubMed: 7479741] [Full Text: https://doi.org/10.1073/pnas.92.22.10137]
(Video) Online Mendelian Inheritance in Man (OMIM): A Genetic Disorder Database -
Dominov, J. A., Kravetz, A. J., Ardelt, M., Kostek, C. A., Beermann, M. L., Miller, J. B. Muscle-specific BCL2 expression ameliorates muscle disease in laminin alpha-2-deficient, but not in dystrophin-deficient, mice. Hum. Molec. Genet. 14: 1029-1040, 2005. [PubMed: 15757977] [Full Text: https://doi.org/10.1093/hmg/ddi095]
-
Farlie, P. G., Dringen, R., Rees, S. M., Kannourakis, G., Bernard, O. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Nat. Acad. Sci. 92: 4397-4401, 1995. [PubMed: 7753817] [Full Text: https://doi.org/10.1073/pnas.92.10.4397]
-
Fesus, L., Davies, P. J. A., Piacentini, M. Apoptosis: molecular mechanisms in programmed cell death. Europ. J. Cell Biol. 56: 170-177, 1991. [PubMed: 1802705]
-
Fonseca-Pereira, D., Arroz-Madeira, S., Rodrigues-Campos, M., Barbosa, I. A. M., Domingues, R. G., Bento, T., Almeida, A. R. M., Ribeiro, H., Potocnik, A. J., Enomoto, H., Veiga-Fernandes, H. The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function. Nature 514: 98-101, 2014. [PubMed: 25079320] [Full Text: https://doi.org/10.1038/nature13498]
-
Frankel, S. R. Correction: location of bcl-2 oncogene. (Letter) New Eng. J. Med. 328: 141, 1993. [PubMed: 8416434] [Full Text: https://doi.org/10.1056/NEJM199301143280216]
-
Graninger, W. B., Seto, M., Boutain, B., Goldman, P., Korsmeyer, S. J. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J. Clin. Invest. 80: 1512-1515, 1987. [PubMed: 3500184] [Full Text: https://doi.org/10.1172/JCI113235]
-
Haluska, F. G., Tsujimoto, Y., Croce, C. M. Mechanisms of chromosome translocation in B- and T-cell neoplasia. Trends Genet. 3: 11-15, 1987.
-
He, C., Bassik, M. C., Moresi, V., Sun, K., Wei, Y., Zou, Z., An, Z., Loh, J., Fisher, J., Sun, Q., Korsmeyer, S., Packer, M., May, H. I., Hill, J. A., Virgin, H. W., Gilpin, C., Xiao, G., Bassel-Duby, R., Scherer, P. E., Levine, B. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481: 511-515, 2012. Note: Erratum: Nature 503: 146 only, 2013. [PubMed: 22258505] [Full Text: https://doi.org/10.1038/nature10758]
-
Hengartner, M. O., Horvitz, H. R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76: 665-676, 1994. [PubMed: 7907274] [Full Text: https://doi.org/10.1016/0092-8674(94)90506-1]
-
Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990. [PubMed: 2250705] [Full Text: https://doi.org/10.1038/348334a0]
-
Hoyer-Hansen, M., Bastholm, L., Szyniarowski, P., Campanella, M., Szabadkai, G., Farkas, T., Bianchi, K., Fehrenbacher, N., Elling, F., Rizzuto, R., Mathiasen, I. S., Jaattela, M. Control of macrophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Molec. Cell 25: 193-205, 2007. [PubMed: 17244528] [Full Text: https://doi.org/10.1016/j.molcel.2006.12.009]
-
Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C., Raff, M. C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369, 1993. [PubMed: 8381212] [Full Text: https://doi.org/10.1038/361365a0]
-
Ji, L., Mochon, E., Arcinas, M., Boxer, L. M. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. J. Biol. Chem. 271: 22687-22691, 1996. [PubMed: 8798441] [Full Text: https://doi.org/10.1074/jbc.271.37.22687]
-
Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-886, 1992. [PubMed: 1498330]
(Video) |OMIM|Online Mendelian inheritance in man|omim -
Lang, G., Gombert, W. M., Gould, H. J. A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene. Immunology 114: 25-36, 2005. [PubMed: 15606792] [Full Text: https://doi.org/10.1111/j.1365-2567.2004.02073.x]
-
Li, Q. J., Ashraf, M. F., Shen, D., Green, W. R., Stark, W. J., Chan, C.-C, O'Brien, T. P. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch. Ophthal. 119: 1597-1604, 2001. [PubMed: 11709009] [Full Text: https://doi.org/10.1001/archopht.119.11.1597]
-
Limana, F., Urbanek, K., Chimenti, S., Quaini, F., Leri, A., Kajstura, J., Nadal-Ginard, B., Izumo, S., Anversa, P. bcl-2 overexpression promotes myocyte proliferation. Proc. Nat. Acad. Sci. 99: 6257-6262, 2002. [PubMed: 11983915] [Full Text: https://doi.org/10.1073/pnas.092672899]
-
Lin, B., Kolluri, S. K., Lin, F., Liu, W., Han, Y.-H., Cao, X., Dawson, M. I., Reed, J. C., Zhang, X. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116: 527-540, 2004. [PubMed: 14980220] [Full Text: https://doi.org/10.1016/s0092-8674(04)00162-x]
-
Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., Botstein, D., Levy, R. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. New Eng. J. Med. 350: 1828-1837, 2004. [PubMed: 15115829] [Full Text: https://doi.org/10.1056/NEJMoa032520]
-
Marsden, V. S., O'Connor, L., O'Reilly, L. A., Silke, J., Metcalf, D., Ekert, P. G., Huang, D. C. S., Cecconi, F., Kuida, K., Tomaselli, K. J., Roy, S., Nicholson, D. W., Vaux, D. L., Bouillet, P., Adams, J. M., Strasser, A. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634-637, 2002. [PubMed: 12374983] [Full Text: https://doi.org/10.1038/nature01101]
-
Martinou, J.-C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., Pietra, C., Huarte, J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017-1030, 1994. [PubMed: 7946326] [Full Text: https://doi.org/10.1016/0896-6273(94)90266-6]
-
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., Korsmeyer, S. J. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-88, 1989. [PubMed: 2649247] [Full Text: https://doi.org/10.1016/0092-8674(89)90174-8]
-
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., Fisher, D. E. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109: 707-718, 2002. [PubMed: 12086670] [Full Text: https://doi.org/10.1016/s0092-8674(02)00762-6]
-
Migheli, A., Cavalla, P., Piva, R., Giordana, M. T., Schiffer, D. Bcl-2 protein expression in aged brain and neurodegenerative diseases. Neuroreport 5: 1906-1908, 1994. [PubMed: 7841373] [Full Text: https://doi.org/10.1097/00001756-199410000-00016]
-
Mock, B. A., Givol, D., D'Hoostelaere, L. A., Huppi, K., Seldin, M. F., Gurfinkel, N., Unger, T., Potter, M., Mushinski, J. F. Mapping of the bcl-2 oncogene on mouse chromosome 1. Cytogenet. Cell Genet. 47: 11-15, 1988. [PubMed: 2895697] [Full Text: https://doi.org/10.1159/000132495]
-
Mufti, G. J., Hamblin, T. J., Oscier, D. G., Johnson, S. Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations. Blood 62: 1142-1146, 1983. [PubMed: 6605167]
-
Nakayama, K., Nakayama, K., Negishi, I., Kuida, K., Sawa, H., Loh, D. Y. Targeted disruption of Bcl-2-alpha-beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Nat. Acad. Sci. 91: 3700-3704, 1994. [PubMed: 8170972] [Full Text: https://doi.org/10.1073/pnas.91.9.3700]
-
Negrini, M., Silini, E., Kozak, C., Tsujimoto, Y., Croce, C. M. Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 49: 455-463, 1987. [PubMed: 3032455] [Full Text: https://doi.org/10.1016/0092-8674(87)90448-x]
(Video) OMIM (Online Mendelian Inheritance in Man) - GANL 401, MUST. -
Ngan, B.-Y., Chen-Levy, Z., Weiss, L. M., Warnke, R. A., Cleary, M. L. Expression in non-Hodgkin's lymphoma of the BCL-2 protein associated with the t(14;18) chromosomal translocation. New Eng. J. Med. 318: 1638-1644, 1988. [PubMed: 3287162] [Full Text: https://doi.org/10.1056/NEJM198806233182502]
-
Nishimura, E. K., Granter, S. R., Fisher, D. E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307: 720-724, 2005. [PubMed: 15618488] [Full Text: https://doi.org/10.1126/science.1099593]
-
Nunez, G., Hockenbery, D., McDonnell, T. J., Sorensen, C. M., Korsmeyer, S. J. Bcl-2 maintains B cell memory. Nature 353: 71-73, 1991. [PubMed: 1908951] [Full Text: https://doi.org/10.1038/353071a0]
-
Nunez, G., Seto, M., Seremetis, S., Ferrero, D., Grignani, F., Korsmeyer, S. J., Dalla-Favera, R. Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. Proc. Nat. Acad. Sci. 86: 4589-4593, 1989. [PubMed: 2543982] [Full Text: https://doi.org/10.1073/pnas.86.12.4589]
-
O'Brien, S. J., Bonner, T. I., Cohen, M., O'Connell, C., Nash, W. G. Mapping of an endogenous retroviral sequence to human chromosome 18. Nature 303: 74-77, 1983. [PubMed: 6843662] [Full Text: https://doi.org/10.1038/303074a0]
-
Pedrini, S., Sau, D., Guareschi, S., Bogush, M., Brown, R. H., Jr., Naniche, N., Kia, A., Trotti, D., Pasinelli, P. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum. Molec. Genet. 19: 2974-2986, 2010. [PubMed: 20460269] [Full Text: https://doi.org/10.1093/hmg/ddq202]
-
Pegoraro, L., Palumbo, A., Erikson, J., Falda, M., Giovanazzo, B., Emanuel, B. S., Rovera, G., Nowell, P. C., Croce, C. M. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc. Nat. Acad. Sci. 81: 7166-7170, 1984. [PubMed: 6334305] [Full Text: https://doi.org/10.1073/pnas.81.22.7166]
-
Qin, B., Xiao, B., Liang, D., Xia, J., Li, Y., Yang, H. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem. Biophys. Res. Commun. 410: 127-133, 2011. [PubMed: 21640710] [Full Text: https://doi.org/10.1016/j.bbrc.2011.05.118]
-
Raghavan, S. C., Swanson, P. C., Wu, X., Hsieh, C.-L., Lieber, M. R. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 428: 88-93, 2004. [PubMed: 14999286] [Full Text: https://doi.org/10.1038/nature02355]
-
Reed, J. C., Cuddy, M., Slabiak, T., Croce, C. M., Nowell, P. C. Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 336: 259-261, 1988. [PubMed: 2848196] [Full Text: https://doi.org/10.1038/336259a0]
-
Roberts, A. W., Davids, M. S., Pagel, J. M., Kahl, B. S., Puvvada, S. D., Gerecitano, J. F., Kipps, T. J., Anderson, M. A., Brown, J. R., Gressick, L., Wong, S., Dunbar, M., Zhu, M., Desai, M. B., Cerri, E., Enschede S. H., Humerickhouse, R. A., Wierda, W. G., Seymour, J. F. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. New Eng. J. Med. 374: 311-322, 2016. [PubMed: 26639348] [Full Text: https://doi.org/10.1056/NEJMoa1513257]
-
Sagot, Y., Dubois-Dauphin, M., Tan, S. A., de Bilbao, F., Aebischer, P., Martinou, J.-C., Kato, A. C. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15: 7727-7733, 1995. [PubMed: 7472523] [Full Text: https://doi.org/10.1523/JNEUROSCI.15-11-07727.1995]
-
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., Korsmeyer, S. J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888, 1991. [PubMed: 1835668] [Full Text: https://doi.org/10.1016/0092-8674(91)90361-2]
-
Silverman, G. A., Green, E. D., Young, R. L., Jockel, J. I., Domer, P. H., Korsmeyer, S. J. Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire BCL2 protooncogene. Proc. Nat. Acad. Sci. 87: 9913-9917, 1990. [PubMed: 2263642] [Full Text: https://doi.org/10.1073/pnas.87.24.9913]
(Video) OMIM Database -
Strasser, A., Harris, A. W., Cory, S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899, 1991. [PubMed: 1959134] [Full Text: https://doi.org/10.1016/0092-8674(91)90362-3]
-
Sugino, N., Suzuki, T., Kashida, S., Karube, A., Takiguchi, S., Kato, H. Expression of Bcl-2 and Bax in the human corpus luteum during the menstrual cycle in early pregnancy: regulation by human chorionic gonadotropin. J. Clin. Endocr. Metab. 85: 4379-4386, 2000. [PubMed: 11095483] [Full Text: https://doi.org/10.1210/jcem.85.11.6944]
-
Tsujimoto, Y., Bashir, M. M., Givol, I., Cossman, J., Jaffe, E., Croce, C. M. DNA rearrangements in human follicular lymphoma can involve the 5-prime or the 3-prime region of the bcl-2 gene. Proc. Nat. Acad. Sci. 84: 1329-1331, 1987. [PubMed: 3547408] [Full Text: https://doi.org/10.1073/pnas.84.5.1329]
-
Tsujimoto, Y., Cossman, J., Jaffe, E., Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985. [PubMed: 3874430] [Full Text: https://doi.org/10.1126/science.3874430]
-
Tsujimoto, Y., Croce, C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Nat. Acad. Sci. 83: 5214-5218, 1986. [PubMed: 3523487] [Full Text: https://doi.org/10.1073/pnas.83.14.5214]
-
Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-1099, 1984. [PubMed: 6093263] [Full Text: https://doi.org/10.1126/science.6093263]
-
Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393, 1985. [PubMed: 3929382] [Full Text: https://doi.org/10.1126/science.3929382]
-
Tsujimoto, Y. Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc. Nat. Acad. Sci. 86: 1958-1962, 1989. [PubMed: 2538824] [Full Text: https://doi.org/10.1073/pnas.86.6.1958]
-
Vanasse, G. J., Halbrook, J., Thomas, S., Burgess, A., Hoekstra, M. F., Disteche, C. M., Willerford, D. M. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J. Clin. Invest. 103: 1669-1675, 1999. [PubMed: 10377173] [Full Text: https://doi.org/10.1172/JCI6658]
-
Vaskivuo, T. E., Anttonen, M., Herva, R., Billig, H., Dorland, M., Te Velde, E. R., Stenback, F., Heikinheimo, M., Tapanainen, J. S. Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins, and transcription factor GATA-4. J. Clin. Endocr. Metab. 86: 3421-3429, 2001. [PubMed: 11443219] [Full Text: https://doi.org/10.1210/jcem.86.7.7679]
-
Vaux, D. L., Cory, S., Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988. [PubMed: 3262202] [Full Text: https://doi.org/10.1038/335440a0]
-
Wang, H.-G., Rapp, U. R., Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629-638, 1996. [PubMed: 8929532] [Full Text: https://doi.org/10.1016/s0092-8674(00)81383-5]
-
Williams, G. T. Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098, 1991. [PubMed: 1648446] [Full Text: https://doi.org/10.1016/0092-8674(91)90002-g]
-
Yunis, J. J., Frizzera, G., Oken, M. M., McKenna, J., Theologides, A., Arnesen, M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. New Eng. J. Med. 316: 79-84, 1987. [PubMed: 3537802] [Full Text: https://doi.org/10.1056/NEJM198701083160204]
(Video) Online Mendelian Inheritance in Man (ClinGen Biocurator Working Group) -
Yunis, J. J., Mayer, M. G., Arnesen, M. A., Aeppli, D. P., Oken, M. M., Frizzera, G. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. New Eng. J. Med. 320: 1047-1054, 1989. [PubMed: 2648153] [Full Text: https://doi.org/10.1056/NEJM198904203201605]
-
Yunis, J. J., Oken, M. M., Kaplan, M. E., Ensrud, K. M., Howe, R. R., Theologides, A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. New Eng. J. Med. 307: 1231-1236, 1982. [PubMed: 7133054] [Full Text: https://doi.org/10.1056/NEJM198211113072002]
FAQs
What is online Mendelian inheritance in man? ›
Online Mendelian Inheritance in Man (OMIM™) is a comprehensive, authoritative and timely knowledgebase of human genes and genetic disorders compiled to support human genetics research and education and the practice of clinical genetics.
What information does the OMIM online mendelian inheritance in man database provide? ›OMIM® - Online Mendelian Inheritance in Man. ®
The full-text, referenced overviews in OMIM contain information on all known mendelian disorders and over 16,000 genes. OMIM focuses on the relationship between phenotype and genotype. It is updated daily, and the entries contain copious links to other genetics resources.
OMIM is supported by a grant from NHGRI, licensing fees, and generous contributions from people like you.
What is the OMIM page in ncbi? ›OMIM is a comprehensive, authoritative compendium of human genes and genetic phenotypes that is freely available and updated daily. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, under the direction of Dr. Ada Hamosh.
What is an example of Mendelian inheritance in man? ›| Inheritance Pattern | Disease Examples |
|---|---|
| Autosomal Recessive | Tay-sachs disease, sickle cell anemia, cystic fibrosis, phenylketonuria (PKU) |
| X-linked Dominant | Hypophatemic rickets (vitamin D-resistant rickets), ornithine transcarbamylase deficiency |
| X-linked Recessive | Hemophilia A, Duchenne muscular dystrophy |
Examples of human autosomal Mendelian traits include albinism and Huntington's disease. Examples of human X-linked traits include red-green colour blindness and hemophilia.
What does OMIM tell you? ›Online Mendelian Inheritance in Man (OMIM®) is a continuously updated catalog of human genes and genetic disorders and traits, with particular focus on the molecular relationship between genetic variation and phenotypic expression.
Why is OMIM important? ›OMIM ENTRIES. Throughout its history, the primary mission of OMIM has been to collect and curate knowledge on human genes and genetic disorders and traits.
Is OMIM part of ncbi? ›Distribution of OMIM and software development are provided by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM).
Is OMIM a primary database? ›Online Mendelian Inheritance in Man (OMIM), a continuation of Dr Victor A. McKusick's Mendelian Inheritance in Man (MIM) (1), is the primary repository of comprehensive, curated information on genes and genetic phenotypes and the relationships between them.
Who writes OMIM? ›
OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, under the direction of Dr. Ada Hamosh. The OMIM database is made available to the general public subject to certain restrictions.
What is the major gene database funded by the US government? ›GenBank is the NIH genetic sequence database, an annotated collection of all publicly available DNA sequences.
Is OMIM a secondary database? ›OMIM is a secondary database consists of data derived from the analysis of primary data such as sequences, active site residue of proteins and so on. Thus the correct answer is option C.
How do I find my gene name on NCBI? ›A GENE NAME
From the NCBI home page, click on the Search pull-down menu to select the Gene database, type the Gene Name in the text box and click Go. See Gene Help for tips searching Gene. Locate the desired Gene record in the results and click the symbol to open the record.
- Search the Gene database with the gene name, symbol. ...
- Click on the desired gene.
- Click on Reference Sequences in the Table of Contents at the upper right of the gene record.
However, modern studies have revealed that most traits in humans are controlled by multiple genes as well as environmental influences and do not necessarily exhibit a simple Mendelian pattern of inheritance(see “Mendel's Experimental Results”).
What are the three types of Mendelian inheritance? ›Three major patterns of Mendelian inheritance for disease traits are described: autosomal dominant, autosomal recessive, and X-linked (Figure 1.1). Mendelian inheritance patterns refer to observable traits, not to genes.
What are the 5 non-Mendelian inheritance? ›The different types of non-Mendelian inheritance are incomplete dominance, codominance, multiple alleles, sex-linked inheritance, and polygenetic traits.
Do Mendelian laws apply to human beings? ›Human genes do follow Mendelian laws. However, humans are not peas. Although I tried to explain eye color inheritance as a single gene system, scientists now believe that two or three genes are involved in eye color determination./dnaftb/concept_13/con13anigene.
Does Mendelian genetics apply to humans? ›Mendelian traits in humans are human traits that are substantially influenced by Mendelian inheritance. Most — if not all — Mendelian traits are also influenced by other genes, the environment, immune responses, and chance.
What are the Mendelian laws of inheritance in human? ›
Mendel's laws of inheritance include law of dominance, law of segregation and law of independent assortment. The law of segregation states that every individual possesses two alleles and only one allele is passed on to the offspring.
Does my genome determine everything about me? ›Does my genome determine everything about me? Not entirely. Genomes are complicated, and while a small number of your traits are mainly controlled by one gene, most traits are influenced by multiple genes.
What is OMIM 167000? ›Entry - #167000 - OVARIAN CANCER - OMIM.
How do you analyze gene expression data? ›Most of these techniques, including microarray analysis and reverse transcription polymerase chain reaction (RT-PCR), work by measuring mRNA levels. However, researchers can also analyze gene expression by directly measuring protein levels with a technique known as a Western blot.
How many genes with known sequence and phenotype are currently present in OMIM? ›The phenotype–gene relationships are tabulated in OMIM's Morbid Map of the Human Genome (Morbid Map). Currently, over 6200 phenotypes have been attributed to molecular alterations in over 3900 genes (Figure
Which database contains information on mendelian disorders? ›OMIM is a comprehensive, authoritative database that features catalogs of autosomal dominant, autosomal recessive, x-linked, y-linked, and mitochondrial phenotypes. Includes information on human genes and genetic disorders.
Why is it important for us to study the human genome? ›It enables us to: search for genes linked to different types of disease. understand inherited disorders and their treatment. trace human migration patterns from the past.
Is OMIM peer-reviewed? ›OMIM is based on the peer-reviewed biomedical literature. Information in each OMIM entry is cited, and the full reference is provided.
What is the database for genetic mutations? ›The Human Gene Mutation Database (HGMD®) represents an attempt to collate known (published) gene lesions responsible for human inherited diseases. It is a repository of inherited mutation data useful for medical research, genetic diagnosis, and next-generation sequencing studies.
Who is NCBI owned by? ›PubMed Overview
Available to the public online since 1996, PubMed was developed and is maintained by the National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of Health (NIH).
What is the source material for OMIM? ›
The primary source material for OMIM is the published literature. The scientific staff review sev- eral leading journals that publish major articles in clinical and molecular genetics.
What is phenotype mapping key in OMIM? ›Phenotype map key 1: the disorder has been placed on the map based on its association with a gene, but the underlying defect is not known. Phenotype map key 2: the disorder has been placed on the map by linkage; no mutation has been found.
How do you read genomic coordinates? ›Genomic coordinates are directly related to the reference genome and include the chromosome name, start position, and end position in the following format: chr1:1234570-1234870. For more information about genomic coordinates and reference genomes, see our Glossary of common genetic and bioinformatic terms.
Who owns your genome? ›The interpretation of the courts is that once the DNA/tissue leaves the body, it is no longer the property of the individual. The courts seem to be relying on the informed consent contracts that patients sign prior to any procedure, which establishes clear guidelines for the future ownership of said materials.
Who invented gene mapping? ›One hundred years ago, in 1913, Alfred H. Sturtevant helped lay the foundations of modern biology by mapping the relative location of a series of genes on a chromosome.
Is OMIM curated? ›Genome databases for vertebrates and other eukaryotic species. A curated repository of published and unpublished data on human mitochondrial DNA variation.
What American company is the king of genetic sequencing? ›About Illumina
Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.
Regeneron Genetics Center, home to the world's largest and most diverse database of genomes, is digging deeper. By tapping into this vast data resource, scientists at Regeneron are able to make discoveries about human health and genetics that may accelerate the drug development process.
What is the biggest gene sequencing company? ›Illumina
Illumina is the leading provider of sequencing services and sells both instruments and reagents for genome sequencing. Illumina was founded in 1998 and now controls over 80% of the sequencing market. The company reported a 2021 revenue of $4.526 billion and a market cap of $28.92 billion as of September.
Description of MIM/OMIM
It consists of full-text overviews of genes and genetic phenotypes, particularly disorders, and is useful to students, researchers, and clinicians.
What is the name of one public DataBase for data on genetics and genomics? ›
The Genome Database (GDB, http://www.gdb.org ) is a public repository of data on human genes, clones, STSs, polymorphisms and maps.
How do you identify an unknown DNA sequence? ›A computer program can be used to check an unknown DNA sequence for ORFs. The program transcribes each DNA strand into its complementary RNA sequence and then translates the RNA sequence into an amino acid sequence. Each DNA strand can be read in three different reading frames.
How many genes do humans have? ›An international research effort called the Human Genome Project, which worked to determine the sequence of the human genome and identify the genes that it contains, estimated that humans have between 20,000 and 25,000 genes. Every person has two copies of each gene, one inherited from each parent.
How do you find the Snps in a gene NCBI? ›- Select the “SNP” database from the “All Databases” pull down menu (Figure 1.19.1)
- Type rs1815739 in the query box and click on the Go button. ...
- Click on the rs1815739 link to view the full record (Figure 1.19. ...
- Click on the Search link in the dark blue column to the left.
Mendelian inheritance refers to an inheritance pattern that follows the laws of segregation and independent assortment in which a gene inherited from either parent segregates into gametes at an equal frequency.
What is non-Mendelian inheritance in man hereditary diseases? ›Genetic traits located on gonosomes sometimes show specific non-Mendelian inheritance patterns. Individuals can develop a recessive trait in the phenotype dependent on their sex—for example, colour blindness and haemophilia (see gonosomal inheritances).
What are Mendelian diseases in humans? ›Well-known examples of Mendelian diseases include cystic fibrosis, sickle cell disease, and Duchenne muscular dystrophy. Other genetic diseases, including cancer, result from somatic mutations, which occur in individual cells during a person's lifetime.